Seminars in Hematology
Volume 44, Issue 1 , Pages 15-23 , January 2007

Granulocyte Transfusion: Current Status

  • Thomas H. Price

      Affiliations

    • Corresponding Author InformationAddress correspondence to Thomas H. Price, MD, Puget Sound Blood Center, 921 Terry Ave, Seattle, WA 98104.

References 

  1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328:1323–1332
  2. Hughes WT, Armstrong D, Bodey GP, Brown AR, Edwards JE, Feld R, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551–573
  3. Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002;29:15–19
  4. Marr KA, Carter RA, Crippa F. Epidemiology and outcome of mould infections in hematopoietic stem cell tranplant patients. Clin Infect Dis. 2002;34:909–917
  5. Marr KA, Boeckh M, Carter RA. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2004;39:797–802
  6. Wingard JR. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant. 1999;5:55–68
  7. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008
  8. Imhof A, Balajee A, Fredricks DN. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39:743–746
  9. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J-W, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–415
  10. Dutcher JP, Schiffer CA, Johnston GS, Papenburg D, Daly PA, Aisner J, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood. 1983;62:354–360
  11. Dutcher JP, Riggs JR, Fox JJ, Johnston GS, Norris D, Wiernik PH, et al. Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes. Am J Hematol. 1990;33:238–243
  12. Stroncek DF, Leonard K, Eiber G. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009–1015
  13. McCullough J, Clay M, Hurd D. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood. 1986;67:522–528
  14. Hinckley ME, Huestis DW. Premedication for optimal granulocyte collection. Plasma Ther. 1981;2:149–152
  15. Winton EF, Vogler WR. Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator. Blood. 1978;52:249–253
  16. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage. Blood. 1979;54:977–986
  17. Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Eng J Med. 1977;297:1033–1036
  18. Price TH. Neutrophil transfusion (In vivo function of neutrophils collected using cell separators). Transfusion. 1983;23:504–507
  19. Dale DC, Liles WC, Summer WR. Granulocyte colony-stimulating factor: Role and relationships in infectious diseases. J Infect Dis. 1995;172:1061–1075
  20. McCullough J, Weiblen BJ, Fine D. Effects of storage of granulocytes on their fate in vivo. Transfusion. 1983;23:20–24
  21. Glasser L, Lane TA, McCullough J. Panel VII: Neutrophil concentrates—Functional considerations, storage, and quality control. J Clin Apheresis. 1983;1:179–184
  22. McCullough J, Weiblen BJ, Peterson PK. Effects of temperature on granulocyte preservation. Blood. 1978;52:301–310
  23. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med. 1990;323:315–321
  24. Schwarzenberg L, Mathé G, de Grouchy J, deNava C, deVries MJ, Amiel JL, et al. White blood cell transfusions. Isr J Med Sci. 1965;1:925–956
  25. Morse EE, Freireich EJ, Carbone PP. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion. 1966;6:183–192
  26. Lowenthal RM, Grossman L, Goldman JM, Storring RA, Buskare NA, Park DS, et al. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975;1:353–358
  27. Strauss RG. Granulocyte (neutrophil) transfusion. In:  McLeod BC,  Price TH,  Weinstein R editor. Apheresis: Principles and Practice. (ed 2). Bethesda, MD: AABB Press; 2003;p. 237–252/6
  28. Graw RG, Herzig GH, Perry S. Normal granulocyte transfusion therapy: Treatment of septicemia due to gram-negative bacteria. N Engl J Med. 1972;287:367–371
  29. Higby DJ, Yates JW, Henderson ES. Filtration leukapheresis for granulocyte transfusion therapy: Clinical and laboratory studies. N Engl J Med. 1975;292:761–766
  30. Fortuny IE, Bloomfield CD, Hadlock DC. Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia. Transfusion. 1975;15:548–557
  31. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med. 1977;63:548–555
  32. Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977;296:706–711
  33. Herzig RH, Herzig GP, Graw RG. Successful granulocyte transfusion therapy for gram-negative septicemia: A prospectively randomized controlled study. N Engl J Med. 1977;296:701–705
  34. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections: A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982;97:509–515
  35. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood. 1993;81:1675–1678
  36. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis. 1996;11:1–9
  37. Bhatia S, McCullough J, Perry EH. Granulocyte transfusions: Efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion. 1994;34:226–232
  38. Strauss RG. Granulocyte transfusions. In:  Rossi EC,  Simon TL,  Moss GS, et al. editor. Principles of Transfusion Medicine. (ed 2). Baltimore, MD: Williams & Wilkins; 1996;p. 321–328
  39. Strauss RG, Connett JE, Gale R, Bloomfield CD, Herzig GP, McCullough J, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med. 1981;305:597–603
  40. Rosenshein MS, Farewell VT, Price TH. The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. N Engl J Med. 1980;302:1058–1062
  41. Christensen RD, Anstall HB, Rothstein G. Deficiencies in the neutrophil system of newborn infants, and the use of leukocyte transfusions in the treatment of neonatal sepsis. J Clin Apheresis. 1982;1:33–41
  42. Buescher ES, Gallin JI. Leukocyte tranfusions in chronic granulomatous disease: Persistence of transfused leukocytes in sputum. N Engl J Med. 1982;307:800–803
  43. Bowen TJ, Ochs HD, Altman LC, Price TH, Van Epps DE, Brautigan DL, et al. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr. 1982;101:932–940
  44. Wright DG, Robichaud KJ, Pizzo PA. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981;304:1185–1189
  45. Dutcher JP, Kendall J, Norris D. Granulocyte transfusion therapy and amphotericin B: Adverse reactions?. Am J Hematol. 1989;31:102–108
  46. Dana BW, Durie BG, White RF. Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood. 1981;57:90–94
  47. Pegels JG, Bruynes ECE, Engelriet CP. Serological studies in patients on platelet- and granulocyte-substitution therapy. Br J Haematol. 1982;52:59–68
  48. Arnold R, Goldmann SF, Pflieger H. Lymphocytotoxic antibodies in patients receiving granulocyte transfusion. Vox Sang. 1980;38:250–258
  49. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood. 2000;95:3302–3309
  50. Adkins DR, Goodnough LT, Shenoy S. Effect of leukocyte incompatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood. 2000;95:3605–3612
  51. Appelbaum FR, Bowles CA, Makuch RW. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: Study of cell dose and collection technique. Blood. 1978;52:323–331
  52. Epstein RB, Chow HS. An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion. 1981;21:360–362
  53. Chatta GS, Price TH, Allen RC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood. 1994;84:2923–2929
  54. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996;88:335–340
  55. Liles WC, Huang JE, Llewellyn C. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion. 1997;37:182–187
  56. Stroncek DF, Clay ME, Petzoldt ML. Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion. 1996;36:601–610
  57. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion. 1996;36:590–595
  58. Liles WC, Klebanoff SJ. Regulation of apoptosis in neutrophils: Fast track to death?. J Immunol. 1995;155:3289–3291
  59. Hester JP, Dignani MC, Anaissie EJ. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis. 1995;10:188–193
  60. Adkins D, Spitzer G, Johnston M. Transfusions of granulocyte-colony-stimulating factor–mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion. 1997;37:737–748
  61. Dale DC, Liles WC, Llewellyn C. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion. 1998;38:713–721
  62. Adkins D, Goodgold H, Hendershott L. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1997;19:809–812
  63. Grigg A, Vecchi L, Bardy P. G-CSF–stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med. 1996;26:813–818
  64. Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming DE, Massey E, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol. 2003;123:114–118
  65. Peters C, Minkov M, Matthes-Martin S, Potshger U, Witt V, Mann G, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haemotol. 1999;106:689–696
  66. Rutella S, Pierelli L, Piccirillo N, Sica S, Serafini R, Chiusolo P, et al. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy. 2003;5:19–30
  67. Nichols WG, Strauss RG, Ambruso D, King K, Rolston K, Sinner P, et al. G-CSF-stimulated granulocyte transfusions from unrelated community donors for severe infections during neutropenia: A phase II multicenter trial of feasibility and efficacy. Blood. 2003;102:978a;(abstr)
  68. Lee JJ, Song HC, Chung IJ. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica. 2004;89:632–633
  69. Grigull L, Pulver N, Goudeva L, Sykors K, Linderkamp C, Beilken A, et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer. 2006;14:910–916
  70. Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol. 2002;81:273–281
  71. Mousset S, Hermann S, Klein S, Bialleck H, Duchscherer M, Bomke B, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol. 2005;84:734–741
  72. Oza A, Hallemeier C, Goonough L, Khoury H, Shenoy S, Devine S, et al. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocye transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion. 2006;46:14–23
  73. Hubel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: A comparitive analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414–1421
  74. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia. Cancer. 2004;101:2859–2865
  75. Bensinger WI, Price TH, Dale DC, Applebaum FR, Clift R, Lilleby K, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81:1883–1888

PII: S0037-1963(06)00237-X

doi: 10.1053/j.seminhematol.2006.09.015

Seminars in Hematology
Volume 44, Issue 1 , Pages 15-23 , January 2007

Article Tools